Source:http://linkedlifedata.com/resource/pubmed/id/12406085
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2002-10-30
|
pubmed:abstractText |
ETV6, a member of the Ets family of transcription factors, is frequently rearranged to various translocation partners in human leukaemias. We previously described a CD3+/TCRalpha/beta+ mature T-cell acute lymphoblastic leukaemia (T-ALL) cell line, MT-ALL, carrying a t(1;10;12)(q25; p13;p13) with cytokine-inducible lineage switch into the myeloid lineage. Using reverse transcription polymerase chain reaction with primers complementary to ETV6 and ABL2, two ETV6-ABL2 fusion transcripts were identified in MT-ALL which resulted from alternative splicing of an ABL2 exon. The fusion transcripts code for putative ETV6-ABL2 fusion proteins containing the pointed domain of ETV6 and almost the complete ABL2 protein, including the SH2, SH3 domains and the protein tyrosine kinase domain (PTK). Identical ETV6-ABL2 fusion transcripts have been reported in an acute myeloid leukaemia (AML) M3 cell line, carrying both a t(15;17)(q22;q21) and a t(1;12)(q25;p13) with unusual inducible differentiation to eosinophils, and in a patient with AML-M4eo. Interestingly, the non-rearranged allele of ETV6 in the MT-ALL cell line carries an arginine to histidine (R399H) mutation which affects a conserved amino acid in the ets DNA binding domain.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/ETS translocation variant 6 protein,
http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Proteins, Fusion,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-ets,
http://linkedlifedata.com/resource/pubmed/chemical/Repressor Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/TEL-ABL fusion protein, human
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0007-1048
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
119
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
454-8
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:12406085-Amino Acid Sequence,
pubmed-meshheading:12406085-Animals,
pubmed-meshheading:12406085-Artificial Gene Fusion,
pubmed-meshheading:12406085-Base Sequence,
pubmed-meshheading:12406085-DNA-Binding Proteins,
pubmed-meshheading:12406085-Humans,
pubmed-meshheading:12406085-Leukemia-Lymphoma, Adult T-Cell,
pubmed-meshheading:12406085-Mice,
pubmed-meshheading:12406085-Mice, SCID,
pubmed-meshheading:12406085-Molecular Sequence Data,
pubmed-meshheading:12406085-Oncogene Proteins, Fusion,
pubmed-meshheading:12406085-Point Mutation,
pubmed-meshheading:12406085-Protein-Tyrosine Kinases,
pubmed-meshheading:12406085-Proto-Oncogene Proteins c-ets,
pubmed-meshheading:12406085-Repressor Proteins,
pubmed-meshheading:12406085-Reverse Transcriptase Polymerase Chain Reaction
|
pubmed:year |
2002
|
pubmed:articleTitle |
Identification of an ETV6-ABL2 fusion transcript in combination with an ETV6 point mutation in a T-cell acute lymphoblastic leukaemia cell line.
|
pubmed:affiliation |
Division of Haematology and Oncology, and Department of Internal Medicine, University of Göttingen, Göttingen, Germany. fgriesi@med.uni-goettingen.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|